Sutro Biopharma Ownership | Who Owns Sutro Biopharma?


OverviewForecastRevenueFinancialsChart

Sutro Biopharma Ownership Summary


Sutro Biopharma is owned by 0.21% institutional investors, 4.69% insiders, and 95.11% retail investors. Blackrock is the largest institutional shareholder, holding 11.24% of STRO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.88% of its assets in Sutro Biopharma shares.

STRO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSutro Biopharma0.21%4.69%95.11%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.91M11.24%$20.25M
Affinity asset advisors748.38K8.82%$8.66B
Suvretta capital management6.49M7.67%$5.63M
Kynam capital management, lp5.09M6.02%$4.42M
Tang capital management2.83M3.34%$2.46M
Merck2.72M3.22%$2.37M
Vestal point capital, lp2.60M3.07%$2.26M
Eversept partners, lp2.29M2.71%$1.99M
Samsara biocapital2.20M2.60%$1.91M
Adage capital partners gp2.00M2.36%$1.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Merck2.72M1.04%$2.37M
Aju ib investment17.50K0.89%$202.47K
Affinity asset advisors748.38K0.49%$8.66B
Kynam capital management, lp5.09M0.33%$4.42M
Samsara biocapital2.20M0.25%$1.91M
Suvretta capital management6.49M0.14%$5.63M
Eversept partners, lp2.29M0.14%$1.99M
Vestal point capital, lp2.60M0.10%$2.26M
Tang capital management2.83M0.09%$2.46M
Dafna capital management437.08K0.09%$379.56K

Top Buyers

HolderShares% AssetsChange
Blackrock6.91M0.00%1.21M
Affinity asset advisors748.38K0.49%748.38K
Millennium management703.15K0.00%297.54K
Two sigma investments, lp396.79K0.00%281.72K
Tang capital management2.83M0.09%267.13K

Top Sellers

HolderShares% AssetsChange
Ra capital management---4.43M
Vanguard group---3.68M
Acadian asset management---3.39M
Velan capital investment management lp---3.12M
Point72 asset management---2.20M

New Positions

HolderShares% AssetsChangeValue
Affinity asset advisors748.38K0.49%748.38K$8.66B
Marshall wace, llp85.61K0.00%85.61K$990.57M
Nomura43.43K0.00%43.43K$127.24K
Jane street group22.95K-22.95K$265.47K
Omers administration11.02K0.00%11.02K$127.54K

Sold Out

HolderChange
Sbi securities-2.00
Farther finance advisors-9.00
Nelson, van denburg & campbell wealth management group-13.00
Allspring global investments-15.00
Group one trading-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20253-96.51%17,606-99.97%-0.01%1-96.55%2-93.94%
Sep 30, 202526-74.26%4,544,952-91.82%50.12%6-88.68%12-50.00%
Jun 30, 2025100-14.53%55,566,817-9.91%651.19%52-10.34%24-27.27%
Mar 31, 20259-92.74%19,888,115-68.79%230.40%7-89.06%--100.00%
Dec 31, 2024121-9.70%63,450,8221.49%771.33%62-15.07%359.38%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.42M2.88%-
Vanguard Total Stock Mkt Idx Inv235.62K1.44%-
Baillie Gifford Global Discovery A Acc904.60K1.10%-13.25K
Fidelity Small Cap Index835.21K0.99%-23.86K
iShares Russell 2000 Value ETF728.08K0.86%-
Edinburgh Worldwide Ord555.93K0.67%-194.80K
State St Russell Sm/Mid Cp® Indx NL Cl C502.75K0.60%-
State St Russell Sm/Mid Cp® Indx SL Cl I502.75K0.60%-
Goldman Sachs Small Cp Val Insghts Instl467.61K0.55%-
iShares Biotechnology ETF467.05K0.55%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 15, 2025Gerber Hans-Peter CHIEF SCIENTIFIC OFFICERBuy$13.61K
Oct 15, 2025Chow Gregory K. CFOBuy$16.00K
Oct 15, 2025Chung Jane Chief Executive OfficerBuy$10.01K
Oct 15, 2025MATSUI CONNIE-Buy$39.95K
Oct 15, 2025Pauling David Chief Admin. Ofcr. & GCBuy$9.99K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q45-
2025 Q3--
2025 Q2--
2025 Q1--

STRO Ownership FAQ


Who Owns Sutro Biopharma?

Sutro Biopharma shareholders are primarily institutional investors at 0.21%, followed by 4.69% insiders and 95.10% retail investors. The average institutional ownership in Sutro Biopharma's industry, Biotech Stocks , is 382.12%, which Sutro Biopharma falls below.

Who owns the most shares of Sutro Biopharma?

Sutro Biopharma’s largest shareholders are Blackrock (6.91M shares, 11.24%), Affinity asset advisors (748.38K shares, 8.82%), and Suvretta capital management (6.49M shares, 7.67%). Together, they hold 27.73% of Sutro Biopharma’s total shares outstanding.

Does Blackrock own Sutro Biopharma?

Yes, BlackRock owns 11.24% of Sutro Biopharma, totaling 6.91M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.25M$. In the last quarter, BlackRock increased its holdings by 1.21M shares, a 21.20% change.

Who is Sutro Biopharma’s biggest shareholder by percentage of total assets invested?

Merck is Sutro Biopharma’s biggest shareholder by percentage of total assets invested, with 1.04% of its assets in 2.72M Sutro Biopharma shares, valued at 2.37M$.

Who is the top mutual fund holder of Sutro Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Sutro Biopharma shares, with 2.88% of its total shares outstanding invested in 2.42M Sutro Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools